SIM
VIVO

SummerHaven Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

SummerHaven Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-49,901
Closed -$1.52M – 289
2022
Q2 		$1.52M Hold
49,901
– – 1.02% 3
2022
Q1 		$1.29M Buy
49,901
+2,320
+5% +$55.2K 0.73% 18
2021
Q4 		$971K Hold
47,581
– – 0.52% 74
2021
Q3 		$915K Buy
+47,581
New +$948K 0.54% 53

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SummerHaven Investment Management's VIVO Position: Q3 2022 in Review

SummerHaven Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 49,901 shares — an estimated $1.52M sold.

SummerHaven Investment Management first reported a position in VIVO in Q3 2021 and held it in 4 quarters. The position peaked at $1.52M in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • SummerHaven Investment Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • SummerHaven Investment Management sold 49,901 Meridian Bioscience Inc shares in Q3 2022, an estimated $1.52M.
  • SummerHaven Investment Management first reported a position in Meridian Bioscience Inc in Q3 2021 and held it in 4 quarters.
  • SummerHaven Investment Management's Meridian Bioscience Inc position peaked at $1.52M in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on SummerHaven Investment Management's 13F filing for Q3 2022, filed 20 Oct 2022.